ACADIA Pharmaceuticals (NASDAQ:ACAD) Reaches New 1-Year Low at $14.60

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Get Free Report)’s share price hit a new 52-week low during trading on Wednesday . The company traded as low as $14.60 and last traded at $14.68, with a volume of 628880 shares. The stock had previously closed at $15.09. Analyst Upgrades and Downgrades Several analysts recently weighed in on […]

Related Keywords

Canada , United States , America , Markc Schneyer , Stephen Davis , Stifel Nicolaus , Needham Company , Jump Financial , Citigroup , Morgan Stanley , Pharmaceuticals Daily , G Investment Management Ltd , Nasdaq , Securities Exchange Commission , Pharmaceuticals Company Profile , Mutual Of America Capital Management , Acadia Pharmaceuticals Inc , Qube Research Technologies Ltd , Pharmaceuticals Inc , Pharmaceuticals Price Performance , Royal Bank , Get Free Report , Exchange Commission , America Capital Management , Technologies Ltd ,